Neurocrine Biosciences: all 121 studies
Page 2 of 2. Open to participants first (18), then studies with results posted, then the rest; newest registration first within each.
- Study to Compare DITEST to Testosterone Undecanoate in Adult Men With HypogonadismCompletedNCT02966652Phase 1
- A 5 Treatment Period Pharmacokinetic Study Evaluating Dose Proportionality and Food Effects of Diazoxide Choline Controlled-Release Tablet (DCCR)Status unknownNCT02893618Phase 2
- Safety, Pharmacokinetics and Pharmacodynamics of NBI-77860 in Adolescent Females With Congenital Adrenal HyperplasiaWithdrawnNCT02349503Phase 1
- Safety, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette SyndromeCompletedNCT02256475Phase 1
- Clinical Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi SyndromeCompletedNCT02034071Phase 1/2
- Safety Study of AADC Gene Therapy (VY-AADC01) for Parkinson's DiseaseCompletedNCT01973543Phase 1
- Safety, Tolerability, and Pharmacokinetics of a Single Dose of NBI-98854 in Subjects With Mild,Moderate, or Severe Hepatic InsufficiencyCompletedNCT01916993Phase 1
- Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of NBI-98854 in Healthy SubjectsCompletedNCT01910480Phase 1
- Efficacy and Safety of NBI-98854 in Subjects With Tardive DyskinesiaCompletedNCT01267188Phase 2
- Pharmacokinetic Study of Diazoxide Choline in Hypertriglyeridemic SubjectsCompletedNCT01211860Phase 1
- Efficacy Study of Diazoxide Choline to Treat HypertriglyceridemiaCompletedNCT01211847Phase 2
- Diazoxide Choline Controlled-Release Tablet (DCCR) for Very High TriglyceridesWithdrawnNCT00973271Phase 3
- Open-Label, Single- and Multiple-Dose Pharmacokinetic Study of Diazoxide CholineWithdrawnNCT00901823Phase 1
- A Study to Evaluate NBI-6024 in Adult and Adolescent Patients With New Onset of Type 1 Diabetes MellitusCompletedNCT00873561Phase 1
- Diazoxide Choline in HypertriglyceridemiaCompletedNCT00696475Phase 2
- Open-label Pharmacokinetic Study of Diazoxide Choline Coated vs. Uncoated FormulationsCompletedNCT00688857Phase 1
- An Exploratory Study of NBI-34060 Capsules and Next Day FunctioningWithdrawnNCT00525941Phase 3
- Study Of Indiplon/Placebo With Sertraline In Insomnia Co-Existing With DepressionTerminatedNCT00232167Phase 3
- Evaluation of an Altered Peptide Ligand (NBI-5788) in Patients With Relapsing Multiple Sclerosis (MS)CompletedNCT00079495Phase 2
- Intravenous Interleukin-4 PE38KDEL Cytotoxin in Treating Patients With Recurrent or Metastatic Kidney Cancer, Non-Small Cell Lung Cancer, or Breast CancerCompletedNCT00039052Phase 1
- NBI-3001 Followed by Surgery in Treating Patients With Recurrent Glioblastoma MultiformeCompletedNCT00014677Phase 2